Publications: Western Australian Centre for Thrombosis and Haemostasis

Journal Article

Baker, R.I. and O’Donnell, J.S. (2021) How I treat bleeding disorder of unknown cause. Blood, 138 (19). pp. 1795-1804.

Casari, I., Manfredi, M., Metharom, P. and Falasca, M. (2021) Dissecting lipid metabolism alterations in SARS-CoV-2. Progress in Lipid Research, 82 . Art. 101092.

Elaskalani, O., Domenichini, A., Abdol Razak, N., E. Dye, D., Falasca, M. and Metharom, P. (2020) Antiplatelet drug ticagrelor enhances chemotherapeutic efficacy by targeting the novel P2Y12-AKT Pathway in pancreatic cancer cells. Cancers, 12 (1). Art. 250.

Favaloro, E., Gilmore, G., Arunachalam, S., Mohammed, S. and Baker, R. (2019) Neutralising rivaroxaban induced interference in laboratory testing for lupus anticoagulant (LA): A comparative study using DOAC Stop and andexanet alfa. Thrombosis Research, 180 . pp. 10-19.

Favaloro, E.J., Gilmore, G., Bonar, R., Dean, E., Arunachalam, S., Mohammed, S. and Baker, R. (2020) Laboratory testing for activated protein C resistance: rivaroxaban induced interference and a comparative evaluation of andexanet alfa and DOAC Stop to neutralise interference. Clinical Chemistry and Laboratory Medicine, 58 (8).

Favaloro, E.J., Gilmore, G., Bonar, R., Dean, E., Arunachalam, S., Mohammed, S. and Baker, R. (2020) Reducing the effect of DOAC interference in laboratory testing for factor VIII and factor IX: A comparative study using DOAC Stop and andexanet alfa to neutralize rivaroxaban effects. Haemophilia . Early View.

Fogarty, H., Townsend, L., Morrin, H., Ahmad, A., Comerford, C., Karampini, E., Englert, H., Byrne, M., Bergin, C., O’Sullivan, J.M., Martin‐Loeches, I., Nadarajan, P., Bannan, C., Mallon, P.W., Curley, G.F., Preston, R.J.S., Rehill, A.M., McGonagle, D., Ni Cheallaigh, C., Baker, R.I., Renné, T., Ward, S.E., O’Donnell, J.S., O’Connell, N., Ryan, K., Kenny, D. and Fazavana, J. (2021) Persistent endotheliopathy in the pathogenesis of long COVID syndrome. Journal of Thrombosis and Haemostasis .

Fogarty, H., Ward, S.E., Townsend, L., Karampini, E., Elliott, S., Conlon, N., Dunne, J., Kiersey, R., Naughton, A., Gardiner, M., Byrne, M., Bergin, C., O'Sullivan, J.M., Martin‐Loeches, I., Nadarajan, P., Bannan, C., Mallon, P.W., Curley, G.F., Preston, R.J.S., Rehill, A.M., Baker, R.I., Cheallaigh, C.N., O'Donnell, J.S., O’Connell, N., Ryan, K., Kenny, D. and Fazavana, J. (2022) Sustained VWF‐ADAMTS‐13 axis imbalance and endotheliopathy in long COVID syndrome is related to immune dysfunction. Journal of Thrombosis and Haemostasis . Early View.

Gilmore, G., Baker, R. and Tiao, J. (2022) 289.1 Evaluation of a rapid screening test as an effective tool in decentralizing ADAMTS13 activity testing - report from the rapid assessment of plasma in microangiopathic thrombocytopenia (RAPMAT) study. Research and Practice in Thrombosis and Haemostasis, 6 (S1). PB0292.

Ho, K.M., Rao, S., Honeybul, S., Zellweger, R., Wibrow, B., Lipman, J., Holley, A., Kop, A., Geelhoed, E., Corcoran, T., Misur, P., Edibam, C., Baker, R.I., Chamberlain, J., Forsdyke, C. and Rogers, F.B. (2019) A multicenter Trial of Vena Cava filters in severely injured patients. New England Journal of Medicine, 381 (4). pp. 328-337.

Ho, Y.C., Brake, S.J., Ahuja, K.D.K., Acott, N., Tiao, J., Baker, R. and Adams, M.J.ORCID: 0000-0002-7743-4515 (2022) IgG fractions from patients with antiphospholipid syndrome and systemic lupus erythematosus bind to platelets, but do not affect collagen-induced platelet activation. Biotechnic & Histochemistry .

Lavin, M., Sánchez Luceros, A., Kouides, P., Abdul‐Kadir, R., O’Donnell, J.S., Baker, R.I., Othman, M. and Haberichter, S.L. (2021) Examining international practices in the management of pregnant women with von Willebrand disease. Journal of Thrombosis and Haemostasis . Early View.

Mackie, I., Mancini, I., Muia, J., Kremer Hovinga, J., Nair, S., Machin, S. and Baker, R. (2020) International Council for Standardization in Haematology (ICSH) recommendations for laboratory measurement of ADAMTS13. International Journal of Laboratory Hematology . Early View.

Matasar, M.J., Capra, M., Özcan, M., Lv, F., Li, W., Yañez, E., Sapunarova, K., Lin, T., Jin, J., Jurczak, W., Hamed, A., Wang, M-C, Baker, R., Bondarenko, I., Zhang, Q., Feng, J., Geissler, K., Lazaroiu, M., Saydam, G., Szomor, Á., Bouabdallah, K., Galiulin, R., Uchida, T., Soler, L.M., Cao, A., Hiemeyer, F., Mehra, A., Childs, B.H., Shi, Y. and Zinzani, P.L. (2021) Abstract CT001: CHRONOS-3: Randomized Phase III study of copanlisib plus rituximab vs rituximab/placebo in relapsed indolent non-Hodgkin lymphoma (iNHL). Cancer Research, 81 (13 Suppl.). CT001.

Oh, J., Oh, D., Lee, S.J., Kim, J.H., Kim, N.K., Chong, S.Y., Huh, J.Y. and Baker, R.I. (2019) Prognostic utility of ADAMTS13 activity for the atypical hemolytic uremic syndrome (aHUS) and comparison of complement serology between aHUS and thrombotic thrombocytopenic purpura. Blood Research, 54 (3). pp. 218-228.

Tian, J.ORCID: 0000-0001-9887-7211, Adams, M.J.ORCID: 0000-0002-7743-4515, Tay, J.W.T., James, I., Powell, S., Hughes, Q.W., Gilmore, G., Baker, R.I. and Tiao, J.Y-H. (2021) Estradiol-responsive miR-365a-3p interacts with tissue factor 3′UTR to modulate tissue factor-initiated thrombin generation. Thrombosis and Haemostasis, 121 (11). pp. 1483-1496.

Tiao, J., Powell, S., Gilmore, G., Veedu, R., Wilton, S. and Baker, R. (2020) Splice inducing Antisense Oligonucleotides as a potential gene correction therapy for haemophilia A. Haemophilia, 26 (S4). pp. 21-22.

Ward, S.E., Fogarty, H., Karampini, E., Lavin, M., Schneppenheim, S., Dittmer, R., Morrin, H., Glavey, S., Ni Cheallaigh, C., Bergin, C., Martin‐Loeches, I., Mallon, P.W., Curley, G.F., Baker, R.I., Budde, U., O’Sullivan, J.M., O’Donnell, J.S., O’Connell, N., Byrne, M., Townsend, L., McEvoy, N.L., Clarke, J., Boylan, M., Alalqam, R., Worrall, A.P., Kelly, C., de Barra, E., Preston, R. and Kenny, D. (2021) ADAMTS13 regulation of VWF multimer distribution in severe COVID‐19. Journal of Thrombosis and Haemostasis . Early View.

Zinzani, P.L., Capra, M., Özcan, M., Lv, F., Li, W., Yañez, E., Sapunarova, K., Lin, T., Jin, J., Jurczak, W., Hamed, A., Wang, M.C., Baker, R., Bondarenko, I., Zhang, Q., Feng, J., Geissler, K., Lazaroiu, M., Saydam, G., Szomor, Á., Bouabdallah, K., Galiulin, R., Uchida, T., Mongay Soler, L., Cao, A., Hiemeyer, F., Mehra, A., Childs, B.H., Shi, Y. and Matasar, M.J. (2021) CHRONOS‐3: Randomized phase III study of copanlisib plus rituximab/placebo in relapsed indolent Non-Hodgkin Lymphoma (INHL). Hematological Oncology, 39 (S2).